Orthofix and MTF Biologics Expand Partnership Agreement

Orthofix Medical renewed and expanded its partnership agreement with MTF Biologics. The collaboration extends Orthofix’s exclusive marketing rights to the Trinity™ allograft line through 2032 and includes an expansion agreement to develop a demineralized bone matrix (DBM) that Orthofix will market under the Legacy™ brand name.

Legacy DBM will...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us